19th Annual PEGS Boston Conference and Expo

High-throughput screening of B cell repertoires and antibody libraries can expedite and improve the discovery of therapeutic antibodies. Data-driven discovery strategies are crucial to extract the maximum potential from such data and move from millions of sequences to a diverse set of developable leads. Such strategies require integrating data from the various sequencing and screening platforms and in silico methods to gain a comprehensive understanding of the data. This presentation will discuss recent advancements in wet lab setups and computational screening and how leading companies like Genovac utilize ENPICOM’s IGX Platform in their data-driven discovery workflows.